雅虎香港 搜尋

搜尋結果

  1. special reports. In an interview with MIMS Doctor, Dr Ka-Yuen Lock, Specialist in Endocrinology, Diabetes and Metabolism in Hong Kong, discussed management of diabetes mellitus (DM), including use of ultra-long-acting insulin, in optimizing glycaemic control. She also shared a case study illustrating improvements in glucose variability and ...

  2. Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...

  3. SEARCH. Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India.

  4. Search by appearance. Pill Identifier helps you to identify drugs by visual characteristics. Use marking, shape, form, colours to search medications. Markings (L12A) Shape (Round) Form (Tablet) Color 1 & 2 (Red & Gray) none.

  5. IM Primary vaccination schedule of 2 doses (0.5 mL each): Initial dose followed by 2nd dose 2 mth later. If flexibility in the vaccination schedule is necessary, 2nd dose can be administered between 2 & 6 mth after the 1st dose. Immunodeficient or immunosuppressed individual 2nd dose can be given 1-2 mth after the initial dose.

  6. Four Star. Concise Prescribing Info. Contents. Entecavir. Indications/Uses. Chronic HBV infection in adults w/ compensated liver disease & evidence of active viral replication, persistently elevated serum ALT levels & histological evidence of active inflammation &/or fibrosis. Dosage/Direction for Use. Nucleoside-naïve patient 0.5 mg once daily.

  7. Initial dose should be administered as a 90-min IV infusion. If prior infusion was well tolerated, subsequent doses may be administered as 30-min infusions. Breast cancer 5.4 mg/kg IV infusion once every 3 wk (21-day cycle) until disease progression or unacceptable toxicity. Gastric cancer 6.4 mg/kg IV infusion once every 3 wk (21-day cycle ...

  1. 其他人也搜尋了